The current valuation score of Mesoblast Ltd is 9.86, ranking 6 out of 377 in the Biotechnology & Medical Research industry. Its current P/E ratio is -20.10, which is -100.00% below the recent high of 0.00 and -23.29% above the recent low of -24.78.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.